Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Anticancer Research|May 29, 2008
Adult granulosa cell tumors of the ovary: a clinicopathological study of 34 patients by the Hellenic Cooperative Oncology Group (HeCOG)D Pectasides, G Papaxoinis, G Fountzilas, et al.
Urology|June 18, 2003
The combination of estramustine and mitoxantrone in hormone-refractory prostate cancer: a phase II feasibility study conducted by the Hellenic Cooperative Oncology GroupG F Samelis, D Skarlos, D Bafaloukos, et al.
Cancer Chemotherapy and Pharmacology|November 18, 2006
Weekly administration of topotecan-paclitaxel as second-line treatment in ovarian cancerG P Stathopoulos, N A Malamos, G Aravantinos, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
A phase II study of paclitaxel in platinum pretreated ovarian cancer. A Hellenic Cooperative Oncology Group studyG Aravantinos, D V Skarlos, P Kosmidis, et al.
Cancer Investigation|August 3, 2000
Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: a Hellenic Cooperative Oncology Group Phase II studyG Fountzilas, C Nicolaides, D Bafaloukos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2009
Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) studyG Mountzios, M A Dimopoulos, A Bamias, et al.
Oncology|July 8, 1999
Platinum-based chemotherapy of primary extragonadal germ cell tumours: the Hellenic Cooperative Oncology Group experienceD Pectasides, G Aravantinos, A Visvikis, et al.
Cancer Biomarkers : Section a of Disease Markers|November 27, 2018
Association between genetic polymorphisms in long non-coding RNAs and pancreatic cancer riskD Moschovis, E Vasilaki, M Tzouvala, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology GroupD Pectasides, G Aravantinos, H Kalofonos, et al.
Gynecologic Oncology|June 30, 2000
Paclitaxel and cisplatin in advanced or recurrent carcinoma of the endometrium: long-term results of a phase II multicenter studyM A Dimopoulos, C A Papadimitriou, V Georgoulias, et al.
Pageof 9